Abstract
Abdominal wall calcification in a peritoneal dialysis patient has not previously been reported. We describe a 40-year-old lady, a type 2 diabetic and hypertensive for the past 14 years, who did not have any history, clinical features or laboratory results suggesting autoimmune disease, and had not suffered from tuberculosis in the past, but who had been diagnosed with chronic kidney disease in 2016. She had initiated peritoneal dialysis in December 2018.
Keywords
Case report
Our patient had used combinations of dextrose peritoneal dialysis fluids, and icodextrin. Since June 2020, she was having two 5 L exchanges of 2.5% dextrose peritoneal dialysis fluid with an automated peritoneal dialysis machine at night, and icodextrin during the day. A peritoneal equilibration test revealed a high average transporter status. Her weekly Kt/V adequacy test was 1.7 (lower limit of normal). Her medication included amlodipine (10 mg od), telmisaratan (40 mg bd), calcitriol (0.25 μg od), and sevelamer (400 mg tds).
She presented with a feeling of tightness around her anterior abdomen. Examination revealed firm and pitting oedema of the anterior abdomen with no organomegaly. An abdominal radiograph revealed multiple subcutaneous calcific densities in the anterior abdominal wall, both gluteal regions, and the lateral aspects of both proximal thighs. Further, diffuse vascular calcifications in the aorta, coeliac trunk, splenic artery, common hepatic artery and its branches, both renal arteries and segmental branches, superior, inferior, and bilateral common iliac arteries and their branches (Fig. 1).

Abdominal computed tomography (CT): (a) plain study, axial view showing extensive calcification in the subcutaneous plane of the anterior abdominal wall; (b) coronal view showing extensive vascular calcification involving the aorta and its branches, the common iliac vessels, external and internal iliac artery; (c) coronal view showing subcutaneous calcification in the lateral abdominal wall and gluteal regions.
Laboratory investigations showed an anaemia (Hb 93 g/L), a leucocytosis (11.2 × 109) and normal platelet count (4.45 × 109); serum calcium: 2.62 mmol/L (previous values had risen from 2.2 → 2.3 → 2.35); phosphorus: 2.29 mmol/L; magnesium: 0.86 mmol/L; alkaline phosphatase: 2.56 μkat/L; parathomone: 140.7 pmol/L; vitamin D: 101 nmol/L. The anti-nuclear antigen, anti dsDNA, anti Sm antibody, anti–U1-RNP antibody and anti-centromere antibody tests were all negative. She had a normal serum pH: (7.32), bicarbonate: (19.6 mmol/L), pCO2: (37.2 mm Hg), and pO2: (94.5 mm Hg).
Tc-99m MIBI dual-phase parathyroid scintigraphy (Fig. 2) revealed evidence of an avidfocus in the right lobe inferior pole suggesting a parathyroid adenoma, thus providing a diagnosis of tertiary hyperparathyroidism (Fig. 2). Surgical removal of the adenoma was planned, but our patient sadly succumbed to coronavirus disease 2019 (COVID-19) disease beforehand.

Tc-99m MIBI dual phase parathyroid scintigraphy showing parathyroid adenoma.
Discussion
We found a report of a 39-year-old male who had haemodialysis for 6 years and had multiple nodules along his fingers and palms, which on radiography showed heavily calcified digital arteries with multiple nodular calcifications along the vessels. 1 Further reports are of calcification of abdominal viscera in a patient on peritoneal dialysis suggested sclerosing, encapsulating peritonitis.2,3
Calcinosis cutis, also known as benign nodular calcification, consists of calcium deposition within the cutaneous and subcutaneous tissues without tissue necrosis. Patients usually have firm white papules or plaques and nodules, commonly distributed in the periarticular areas and fingertips. A whitish discharge could be seen from these lesions. 4 It has five types: dystrophic, metastatic, idiopathic, iatrogenic and calciphylaxis. Dystrophic calcinosis cutis occurs in autoimmune conditions such as systemic sclerosis, dermatomyositis and systemic lupus erythematosus.
Metastatic calcification is a consequence of a high calcium phosphate level.
Supplemental Material
sj-jpg-2-tdo-10.1177_00494755231218773 - Supplemental material for Abdominal wall calcification in a peritoneal dialysis patient
Supplemental material, sj-jpg-2-tdo-10.1177_00494755231218773 for Abdominal wall calcification in a peritoneal dialysis patient by M. Gurupriya, G. Anuhya, Mathini Sundarmurthy, Aishwarya P Lakshmi, R. Ram and V Siva Kumar in Tropical Doctor
Supplemental Material
sj-jpg-3-tdo-10.1177_00494755231218773 - Supplemental material for Abdominal wall calcification in a peritoneal dialysis patient
Supplemental material, sj-jpg-3-tdo-10.1177_00494755231218773 for Abdominal wall calcification in a peritoneal dialysis patient by M. Gurupriya, G. Anuhya, Mathini Sundarmurthy, Aishwarya P Lakshmi, R. Ram and V Siva Kumar in Tropical Doctor
Supplemental Material
sj-jpg-4-tdo-10.1177_00494755231218773 - Supplemental material for Abdominal wall calcification in a peritoneal dialysis patient
Supplemental material, sj-jpg-4-tdo-10.1177_00494755231218773 for Abdominal wall calcification in a peritoneal dialysis patient by M. Gurupriya, G. Anuhya, Mathini Sundarmurthy, Aishwarya P Lakshmi, R. Ram and V Siva Kumar in Tropical Doctor
Footnotes
Declaration of conflicting interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
Ethics approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Written Consent for publication
Consent was obtained from the patient's husband.
Supplemental material
Supplemental material for this article is available online.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
